|
Submission MAT-POS-11b63608
|
|
0
|
121
|
September 11, 2020
|
|
Submission MAT-POS-5d20d11c
|
|
0
|
125
|
September 10, 2020
|
|
Submission MAT-POS-bbbbc21a
|
|
0
|
122
|
September 10, 2020
|
|
Submission MAT-POS-b3e365b9
|
|
0
|
111
|
September 9, 2020
|
|
Additional information for PET-UNK-c9c1e0d8 submission
|
|
2
|
422
|
September 9, 2020
|
|
Submission MAT-POS-bfb445d4
|
|
0
|
119
|
September 9, 2020
|
|
Submission RAL-THA-d07c7800
|
|
0
|
110
|
September 9, 2020
|
|
Submission MAT-POS-e501d84c
|
|
0
|
128
|
September 9, 2020
|
|
Submission MAT-POS-e10a589d
|
|
4
|
218
|
September 9, 2020
|
|
Submission RAL-THA-4a5dabff
|
|
0
|
155
|
September 9, 2020
|
|
Submission SWA-SWA-8fdb1140
|
|
0
|
157
|
September 7, 2020
|
|
Submission ALP-POS-8ed8d9ec
|
|
5
|
260
|
September 7, 2020
|
|
Intracellular drug concentration from pharmacokinetic perspective
|
|
0
|
408
|
September 6, 2020
|
|
Submission TAL-GIT-145584f9
|
|
0
|
122
|
September 6, 2020
|
|
Submission TAL-GIT-1fe20059
|
|
0
|
99
|
September 6, 2020
|
|
Submission TAL-GIT-198ceb8d
|
|
0
|
120
|
September 6, 2020
|
|
Submission MAT-POS-f2460aef
|
|
0
|
137
|
September 4, 2020
|
|
New review may be of interest
|
|
0
|
165
|
September 3, 2020
|
|
Submission BEN-DND-93268d01
|
|
9
|
405
|
September 2, 2020
|
|
Submission RYA-MOD-343ecd80
|
|
0
|
127
|
September 2, 2020
|
|
Submission MIC-UNK-9582b2c5
|
|
4
|
162
|
September 1, 2020
|
|
RapidFire IC50 results for isatin LOR-NOR-30067bb9-11
|
|
0
|
434
|
September 1, 2020
|
|
Submission DAR-DIA-667e571f
|
|
0
|
111
|
September 1, 2020
|
|
Submission MAT-POS-1e0c1c67
|
|
3
|
158
|
September 1, 2020
|
|
Submission LH_-UNK-b5bf7f01
|
|
0
|
114
|
August 30, 2020
|
|
Submission JOH-MSK-8ad0fd05
|
|
0
|
155
|
August 30, 2020
|
|
Submission PET-UNK-b75fdf9f
|
|
0
|
106
|
August 29, 2020
|
|
Submission EDJ-MED-a364e151
|
|
1
|
147
|
August 29, 2020
|
|
Submission JOH-MSK-46727e7b
|
|
0
|
119
|
August 28, 2020
|
|
Submission PET-UNK-431b3bfb
|
|
0
|
134
|
August 28, 2020
|